published Jul 8, 2018 5:00:00 PM, by Vinicy Chan and Crystal Tse (Bloomberg) — Investment bankers in Hong Kong are catching biotech fever. At least seven senior bankers and analysts from top-tier securities firms have quit to join biotechnology companies in the city since December, responding to the industry’s growing

published Apr 30, 2018, 8:33:24 AM, by Sonali Basak and Tom Metcalf (Bloomberg) — Few bank CEOs ever become billionaires. Jamie Dimon did. So did Lloyd Blankfein. And then there’s Ken Moelis, a power dealmaker few people outside Wall Street have probably heard of. Since taking his boutique investment bank